SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-19-002610
Filing Date
2019-02-14
Accepted
2019-02-14 17:06:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d0119solensky_zomedica.htm SC 13D 48508
2 OPTION AGREEMENT DATED JANUARY 10, 2019 sc13d0119exasolensky_zomed.htm EX-99.A 45538
  Complete submission text file 0001213900-19-002610.txt   95354
Mailing Address 100 PHOENIX DRIVE SUITE 190 ANN ARBOR MI 48108
Business Address 100 PHOENIX DRIVE SUITE 190 ANN ARBOR MI 48108 (734) 369-2555
Zomedica Pharmaceuticals Corp. (Subject) CIK: 0001684144 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90186 | Film No.: 19608073
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZOMEDICA PHARMACEUTICALS CORP. 100 PHOENIX DRIVE, SUITE 190 ANN ARBOR MI 48108
Business Address
Solensky Gerald JR (Filed by) CIK: 0001721759 (see all company filings)

Type: SC 13D